- CA$12.70m
- CA$13.51m
- 25
- 57
- 10
- 19
Annual cashflow statement for VVT Med, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.2 | -0.243 | -0.138 | -0.184 | -0.158 |
| Depreciation | |||||
| Non-Cash Items | -6.88 | 0 | — | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.19 | 0.073 | 0.026 | 0.09 | 0.058 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.419 | -0.169 | -0.112 | -0.093 | -0.1 |
| Capital Expenditures | -0.006 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.006 | 0 | — | — | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | — | — | — |
| Financing Cash Flow Items | -0.06 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.299 | 0.115 | 0.11 | 0.1 | 0.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.12 | -0.054 | -0.002 | 0.007 | 0 |